Rebecca Araujo

DocwireNews

This week, researchers from the Dana-Farber Cancer Institute collaborated with the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research (AACR) to release recommendations for increasing the representation of African American patients in clinical trials for multiple myeloma (MM). To develop these recommendations, researchers, providers, patients, and industry partners came together with regulators at an FDA-AACR sponsored workshop to outline a &ldquo;roadmap&rdquo; to improved enrollment.https://www.docwirenews.com/urban-health-today/urban-health-multiple-myeloma-knowledge-hub/urban-health-multiple-myeloma-picks/new-recommendations-to-improve-racial-disparities-in-mm-drug-trials/&ndash;According to a systematic review published in JCO Global Oncology, delays and interruptions in cancer care as a result of the COVID-19 pandemic affected many patients. The study authors called the frequency of delays &ldquo;remarkable, showing a relevant impact of the pandemic on the care of patients with cancer.&rdquo; They added, &ldquo;From now and on the basis of these findings, strategies can be proposed to mitigate the main delays and disruptions.&rdquo;https://www.docwirenews.com/docwire-pick/hem-onc-picks/covid-19-pandemic-caused-delays-in-cancer-care/&ndash;Results from the phase 3 HERO trial recently demonstrated superior suppression of testosterone levels with relugolix compared to leuprolide with fewer major adverse cardiovascular events in men with advanced prostate cancer. In a poster presented during the 2021 American Society of Clinical Oncology Genitourinary Cancers Symposium, the investigators presented a subgroup analysis from the trial of 125 patients who received concomitant prostate cancer treatments showing relugolix maintained similar efficacy in this group.https://www.docwirenews.com/docwire-pick/hem-onc-picks/relugolix-effectively-suppresses-testosterone-levels-regardless-of-other-simultaneous-prostate-cancer-treatments/&ndash;A model found that rates of pancreatic cancer mortality were not predicted to improve across Europe in 2021 and may even increase among women. Using this data, which was published in the Annals of Oncology, the research team have called on European health care policymakers to invest in resources to improve diagnosis and treatment of pancreatic cancer to improve these numbers.https://www.docwirenews.com/docwire-pick/pancreatic-cancer-mortality-predicted-to-rise-among-european-women/

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Hem/Onc Roundup: Eliminating Disparity in MM Trials; Plus, Cancer Care in the Pandemic

Oncology

This week, researchers from the Dana-Farber Cancer Institute collaborated with the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe